DeepMed Research

Acetate

Generic Name: Acetate

Drug Type: Small Molecule

Chemical Formula: C_₂H_₃O_₂

CAS Number: 71-50-1

Unique Ingredient Identifier: 569DQM74SC

Clinical Trials

Continuation of Subcutaneous and Intramuscular Depot Medroxyprogesterone Acetate in Post-abortion Patients

Phase 4

Recruiting

Conditions: Contraception

Interventions: Drug: Depot-Medroxyprogestereone Acetate

First Posted Date: 2022-08-17

Last Posted Date: 2024-03-27

Lead Sponsor: Northwestern University

Target Recruit Count: 653

Registration Number: NCT05505435

Locations: 🇺🇸
Family Planning Associates, Chicago, Illinois, United States

Comparing the Hemodynamic Effects of Volume Loading vs Non-loading During Induction of Anesthesia in Fluid Responder Patients With Coronary Artery Disease Undergoing Elective Coronary Artery Bypass Graft Surgery: a Randomized Controlled Study.

Not Applicable

Completed

Conditions: Post Induction Hypotension

Interventions: Drug: Ringer acetate

First Posted Date: 2022-07-18

Last Posted Date: 2022-07-18

Lead Sponsor: Kasr El Aini Hospital

Target Recruit Count: 50

Registration Number: NCT05462847

Locations: 🇪🇬
Kasr Al Ainy, Cairo, Egypt

This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c in Combination With Fluvestrant ± Goseraline Versus Placebo Combined With Fulvestrant ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.

Phase 3

Conditions: Female Breast Cancer
Advanced Breast Cancer

Interventions: Drug: Placebo,Fulvestrant,Goserelin acetate
Drug: FCN-437c,Fulvestrant,Goserelin acetate

First Posted Date: 2022-06-30

Last Posted Date: 2022-07-05

Lead Sponsor: Ahon Pharmaceutical Co., Ltd.

Target Recruit Count: 312

Registration Number: NCT05438810

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia

Phase 2

Recruiting

Conditions: Atypical Endometrial Hyperplasia
Fertility Issues
Overweight and Obesity

Interventions: Behavioral: Intensive Lifestyle Intervention (ILI)
Drug: Megestrol Acetate 160 MG Oral Tablet
Drug: Levonorgestrel-Releasing Intrauterine Contraceptive System (Mirena), 52 Mg

First Posted Date: 2022-04-07

Last Posted Date: 2024-07-19

Lead Sponsor: Xiaojun Chen

Target Recruit Count: 172

Registration Number: NCT05316493

Locations: 🇨🇳
Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China

Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma

Phase 2

Recruiting

Conditions: Obese
Overweight
Fertility Issues
Endometrial Carcinoma

Interventions: Behavioral: Intensive Lifestyle Intervention (ILI)
Drug: Megestrol Acetate 160 MG Oral Tablet

First Posted Date: 2022-04-07

Last Posted Date: 2024-08-13

Lead Sponsor: Xiaojun Chen

Target Recruit Count: 89

Registration Number: NCT05316467

Locations: 🇨🇳
Obstetrics and Gynecology Hospital, Fudan University, Shanghai, Shanghai, China

Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer

Phase 2

Recruiting

Conditions: Endometrial Neoplasm Malignant Stage I

Interventions: Drug: Megestrol Acetate 160 MG Oral Tablet
Drug: Triprorelin Acetate
Drug: Medroxyprogesterone Acetate 500 MG
Drug: Letrozole 2.5mg

First Posted Date: 2022-02-18

Last Posted Date: 2025-04-06

Lead Sponsor: Fudan University

Target Recruit Count: 104

Registration Number: NCT05247268

Locations: 🇨🇳
Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China

Effect of Using Dextrose-containing Intraoperative Fluid in Children

Not Applicable

Conditions: Pediatric Surgery

Interventions: Drug: Ringer acetate
Drug: Dextrose 5
Drug: 1.25%Dextrose equivalence
Drug: 2.5%Dextrose equivalence

First Posted Date: 2021-09-30

Last Posted Date: 2021-09-30

Lead Sponsor: Mahidol University

Target Recruit Count: 68

Registration Number: NCT05061836

Locations: 🇹🇭
Siriraj Hospital, Bangkok noi, Bangkok, Thailand

The Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer

Phase 2

Completed

Conditions: Prostatectomy
Oligometastatic Prostate Cancer
Abiraterone

Interventions: Procedure: robot assisted laparoscopic prostatectomy + enlarged pelvic lymph node dissection
Drug: 1.Abiraterone Acetate Tablets
Drug: Prednisone Acetate Tablets
Drug: Luteinizing Hormone-Releasing Hormone Analog

First Posted Date: 2021-08-05

Last Posted Date: 2024-12-05

Lead Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Target Recruit Count: 130

Registration Number: NCT04992026

Locations: 🇨🇳
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China

Understanding the Metabolic and Functional Derangement of Primary Mitral Regurgitation: a Feasibility Study Using Carbon 11(C-11) Acetate Cardiac Positron Emission Tomography Magnetic Resonance Imaging (PET-MRI)

Early Phase 1

Withdrawn

Conditions: Mitral Valve Regurgitation

Interventions: Drug: [11C] acetate

First Posted Date: 2021-03-12

Last Posted Date: 2025-01-24

Lead Sponsor: University of Alabama at Birmingham

Target Recruit Count: 12

Registration Number: NCT04795856

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States

Evaluation of Safety of Contraloid Acetate in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease

Phase 1

Completed

Conditions: Mild Cognitive Impairment Due to Alzheimer's Disease

Interventions: Drug: Contraloid acetate
Drug: Placebo

First Posted Date: 2021-01-15

Last Posted Date: 2022-08-23

Lead Sponsor: Charite University, Berlin, Germany

Target Recruit Count: 19

Registration Number: NCT04711486

Locations: 🇩🇪
Charité University Medicine, Berlin, Germany

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy